Company Filing History:
Years Active: 2012
Title: Lisa Esther Dalrymple Meyr: Innovator in Kinase Modulation
Introduction
Lisa Esther Dalrymple Meyr is a notable inventor based in San Leandro, California. She has made significant contributions to the field of biochemistry, particularly in the development of kinase modulators. Her work focuses on creating compounds that can effectively inhibit specific kinases, which play crucial roles in various cellular activities.
Latest Patents
Lisa holds a patent for "Pyrimidine derivatives as kinase modulators and method of use." This invention provides compounds and methods for the inhibition of kinases, specifically targeting IGF 1 R kinases and wildtype Abl. The compounds developed by Lisa are designed to modulate protein kinase enzymatic activity, influencing cellular processes such as proliferation, differentiation, programmed cell death, migration, and chemoinvasion. The patent includes compositions containing these compounds and outlines methods for treating kinase-dependent diseases and conditions.
Career Highlights
Lisa is currently employed at Exelixis, Inc., where she continues her research and development in the field of kinase modulation. Her innovative approach has led to advancements in therapeutic strategies for various diseases. With her expertise, she has contributed to the understanding of kinase receptor signal transduction pathways and their impact on cellular activities.
Collaborations
Throughout her career, Lisa has collaborated with esteemed colleagues, including Jeff Z Chen and Sergey Epshteyn. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.
Conclusion
Lisa Esther Dalrymple Meyr is a pioneering inventor whose work in kinase modulation has the potential to transform treatment options for kinase-dependent diseases. Her contributions to the field exemplify the importance of innovation in biochemistry and medicine.